Peng Tao, Zhou Lixiang, Zuo Ling, Luan Yongxin
Department of Neurosurgery, First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Department of Ophthalmology, Second Bethune Hospital of Jilin University, Changchun, Jilin 130041, P.R. China.
Oncol Rep. 2022 Jan;47(1). doi: 10.3892/or.2021.8212. Epub 2021 Nov 2.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blot assay data shown in Figs. 4D, 6B and 7F were strikingly similar to data appearing in different form in other articles by different authors. Furthermore, an independent investigation of this paper conducted by the Editorial Office unveiled possible anomalies associated with the cyclin D1 data presented in Fig. 4D. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors themselves requested that the paper be retracted. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 35: 1057‑1064, 2016; DOI: 10.3892/or.2015.4406].
在本文发表后,一位关注此事的读者提醒编辑注意,图4D、6B和7F中所示的某些蛋白质印迹分析数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。此外,编辑部对本文进行的独立调查发现了与图4D中呈现的细胞周期蛋白D1数据相关的可能异常情况。由于上述文章中有争议的数据在提交给本期刊之前就已在考虑发表或已经发表,编辑决定将本文从本期刊撤回。作者本人也要求撤回该论文。编辑就由此造成的不便向读者表示歉意。[原文发表于《肿瘤学报道》35: 1057 - 1064,2016;DOI: 10.3892/or.2015.4406]